Physician

Ahmet Selcuk Can, M.D.

According to 2025 Medicare claims, Ahmet Can, M.D. (NPI: 1518214626) practices endocrinology in the Lakewood-New Brunswick, NJ market, with the plurality of this provider's patient population coming from Ocean, NJ. This provider's primary affiliated billing organization is HACKENSACK MERIDIAN HEALTH MEDICAL GROUP - SPECIALTY CARE PC (NPI: 1215989249; TIN: 223376459) and primary practice location at 08753-2974.

Can's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 524 traditional Medicare patients, billed 2,266 HCPCS/CPT codes, and received $114,466 in Medicare payments. The top billing code was 99204 (New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more). Part D data shows 5,211 prescription claims across 669 beneficiaries totaling $2,196,675 in drug costs, led by Ozempic (Semaglutide). DME data shows 545 claims. Open Payments data shows 52 records totaling $924. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $2,744 to $114,466. Similarly, Part D prescription costs have moved sharply higher in recent years, from $4,573 to $2,196,675. For DME billing, reported payments moved sharply higher in recent years, from $12,357 to $129,641.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	34	62	$2,744
2018	273	695	$49,975
2019	216	512	$33,356
2020	183	525	$28,073
2021	220	529	$34,138
2022	243	687	$41,960
2023	491	1,545	$96,911
2024	524	2,266	$114,466

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	18	23	$4,573
2018	219	1,738	$577,423
2019	248	2,466	$841,369
2020	238	2,297	$879,494
2021	295	2,499	$1,041,097
2022	371	3,214	$1,601,078
2023	791	3,559	$2,039,320
2024	669	5,211	$2,196,675

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	63	199	$8,808
2019	66	319	$22,005
2020	72	259	$19,343
2021	60	276	$35,406
2022	64	306	$40,368
2023	147	508	$78,343
2024	189	545	$127,212

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	110	110	$131
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	442	856	$98
95251	Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report	67	131	$28
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	304	444	$13
82962	Blood glucose (sugar) test performed by hand-held instrument	315	653	$3

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Ozempic	Semaglutide	571	27,405	$838,664
Rybelsus	Semaglutide	75	4,530	$133,745
Mounjaro	Tirzepatide	98	3,484	$121,595
Jardiance	Empagliflozin	74	4,980	$94,547
Januvia	Sitagliptin Phosphate	77	4,414	$75,246

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4239	Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service	N	65	235	$107,098
A4238	Supply allowance for adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service	N	N/R	16	$7,127
E0784	External ambulatory infusion pump, insulin	Y	N/R	14	$4,641
A4253	Blood glucose test or reagent strips for home blood glucose monitor, per 50 strips	N	87	177	$3,664
A4224	Supplies for maintenance of insulin infusion catheter, per week	N	N/R	15	$3,378

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	52	$924	Novo Nordisk Inc
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Ahmet Selcuk Can, M.D.?

Tedicare shows public-source Medicare data for Ahmet Selcuk Can, M.D. (NPI 1518214626), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Ahmet Selcuk Can, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Ahmet Selcuk Can, M.D.?

Ahmet Selcuk Can, M.D. is linked to HACKENSACK MERIDIAN HEALTH MEDICAL GROUP - SPECIALTY CARE PC (billing NPI 1215989249) in the available physician profile data.

Does Ahmet Selcuk Can, M.D. have Open Payments data?

Ahmet Selcuk Can, M.D. has 52 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.